Geron Corporation (LON:0IV3)
London · Delayed Price · Currency is GBP · Price in USD 1.600
-0.038 (-2.32%)
Feb 12, 2026, 5:03 PM GMT
Geron Market Cap
Geron has a market cap or net worth of 763.85 million as of February 12, 2026. Its market cap has decreased by -45.65% in one year.
Market Cap
763.85M
Enterprise Value
545.32M
Revenue
136.44M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.60
Market Cap Chart
Since July 31, 1996, Geron's market cap has increased from 4.63M to 763.85M, an increase of 16,402.29%. That is a compound annual growth rate of 18.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 763.85M | 22.01% |
| Dec 31, 2025 | 626.07M | -63.37% |
| Dec 31, 2024 | 1.71B | 90.01% |
| Dec 29, 2023 | 899.60M | 17.49% |
| Dec 30, 2022 | 765.70M | 163.97% |
| Dec 31, 2021 | 290.07M | -19.77% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 215.40B |
| GSK plc | 86.64B |
| Haleon | 34.95B |
| Smith & Nephew | 10.82B |
| Oxford Nanopore Technologies | 1.36B |
| Oxford Biomedica | 1.00B |
| CVS Group | 958.33M |
| Spire Healthcare Group | 806.75M |